science

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

A new study tries to put a number on the value of reliable numbers

Philip R. Lane: Climate change and monetary policy

York Space Systems to acquire Solestial

Trump said he is increasing the number of products on the platform by nearly seven times, adding more than 600 generic drugs to the site.

Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that the bigger obstacle is access, and that Claude solves it.

Form 144 Madrigal Pharmaceuticals For: 18 May

TrumpRx set to expand into generic medicines with Mark Cuban

AstraZeneca wins US FDA approval for hypertension drug Baxfendy

United Therapeutics' ralinepag meets primary endpoint in PAH study